|
|
Article: Sparta Pharmaceuticals Inc. announces patent approval from the United States Patent and Trademark Office.
- Article from:
- Business Wire
- Article date:
- July 1, 1997
CopyrightCOPYRIGHT 1997 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
HORSHAM, Pa.--(BUSINESS WIRE)--July 1, 1997--Sparta Pharmaceuticals Inc. (NASDAQ: SPTA, SPTAU, SPTAW, SPTAZ and SPTAL) announced that the United States Patent and Trademark Office has granted United States Patent No. 5,637,479 submitted by Dr. Harvey Rubin and colleagues of The University of Pennsylvania (Penn).
The patent is entitled, "A Method of Modulating DNA Binding Activity of Recombinant alpha-1-Antichymotrypsin and Other Serine Protease Inhibitors." This is the sixth United States patent to be granted through Sparta's collaboration with Penn.
Through a Sparta funded grant, Rubin, who is a scientific advisor to the company, has created a ...